Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials
Aernoud T.L. Fiolet(University Medical Center Utrecht), Peter J. Kelly(University College Dublin), Jan H. Cornel(Brigham and Women's Hospital), Georgios Tsivgoulis(University of Tennessee Health Science Center), Robin Lemmens(KU Leuven), Christian Weimar(University of Duisburg-Essen), Christopher Price(Newcastle University), Michiel H.F. Poorthuis(University Medical Center Utrecht), Cathal Walsh(Trinity College Dublin), Ian Buysschaert(University of Utah), Arend Mosterd(Werkgroep Cardiologische centra Nederland), Jean‐Claude Tardif(Montreal Heart Institute), Binita Shah(New York University), Tjerk S.J. Opstal(Amsterdam University Medical Centers), Noel Chan(McMaster University), Charley Budgeon(The University of Western Australia), Domingo A. Pascual‐Figal(Centro de Investigación Biomédica en Red), Jamie Layland(Peninsula Health), Stefan M. Nidorf(Harry Perkins Institute of Medical Research), John W. Eikelboom(King's College Hospital), Kevin E. Boczar(University of Ottawa), Yongjun Wang(Beijing Tian Tan Hospital), Peter L. Thompson(The University of Western Australia), Jan G.P. Tijssen(University of Amsterdam), Nathan Mewton(Hospices Civils de Lyon), Pierre Amarenco(Population Health Research Institute), Sanjit S. Jolly(University Health Network)
Cited by 56
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Autophagy regulates lipid metabolism
|Nature|2009|3.9k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k